comprehensive -WSS

comprehensive

author：hotspot 2025-09-29 01:06:57 - browse：869

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Why are elite athletes different? Take a look at their microbes

WSS

Biotech investment managers search for lucrative opportunities

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Readout Newsletter: Illumina, CRISPR, Regeneron

Gene therapy has helped boys walk. Can scientists keep it that way?

Chinese researcher claims birth of first gene

The battle over the Brookhaven Landfill on Long Island

focus

comprehensive

hotspot

Apple is now the first public company to be valued at $3 trillion

Biotech investment managers search for lucrative opportunities

Dobbs anniversary: the lost opportunity of abortion as health care

What would happen to your eyes if you looked at the solar eclipse?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The strategy behind pharma's lawsuits over drug pricing reform

Virginia high school admissions case could be legal follow

Readout LOUD podcast, live from the STAT Breakthrough Summit East

New air purifier tech could be key to improving indoor air quality

Pfizer, Moderna say biotech, pharma drug development is a sprint

focus

Colonoscopy at 40? Study finds a possible benefit

Bring on the sabbaticals for nurses

Pfizer, Moderna say biotech, pharma drug development is a sprint

The story of mRNA: From a loose idea to a tool that may help curb Covid

Steward Health Care expansion into Malta flopped

Donald Trump's relentless attacks on special counsel Jack Smith

hotspot

Wikipedia

entertainment

hotspot